These results provided powerful evidence that silencing BMI1 expression contributed to a reduction in the migration of bladder cancer, and suggested that BMI1 was significantly associated with the metastatic ability of bladder cancer. The gene discussed is BMI1; the disease is urinary bladder cancer.